⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VRAX News
Virax Biolabs Group Limited Ordinary Shares
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders
prnewswire.com
VRAX
NASDAQ
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
prnewswire.com
VRAX
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
prnewswire.com
VRAX
Virax Biolabs Group Limited Announces $5 Million Private Placement
prnewswire.com
VRAX
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
prnewswire.com
VRAX
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
prnewswire.com
VRAX
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
prnewswire.com
VRAX